Literature DB >> 21788493

Erionite exposure in North Dakota and Turkish villages with mesothelioma.

Michele Carbone1, Y Izzettin Baris, Pietro Bertino, Brian Brass, Sabahattin Comertpay, A Umran Dogan, Giovanni Gaudino, Sandro Jube, Shreya Kanodia, Charles R Partridge, Harvey I Pass, Zeyana S Rivera, Ian Steele, Murat Tuncer, Steven Way, Haining Yang, Aubrey Miller.   

Abstract

Exposure to erionite, an asbestos-like mineral, causes unprecedented rates of malignant mesothelioma (MM) mortality in some Turkish villages. Erionite deposits are present in at least 12 US states. We investigated whether increased urban development has led to erionite exposure in the United States and after preliminary exploration, focused our studies on Dunn County, North Dakota (ND). In Dunn County, ND, we discovered that over the past three decades, more than 300 miles of roads were surfaced with erionite-containing gravel. To determine potential health implications, we compared erionite from the Turkish villages to that from ND. Our study evaluated airborne point exposure concentrations, examined the physical and chemical properties of erionite, and examined the hallmarks of mesothelial cell transformation in vitro and in vivo. Airborne erionite concentrations measured in ND along roadsides, indoors, and inside vehicles, including school buses, equaled or exceeded concentrations in Boyali, where 6.25% of all deaths are caused by MM. With the exception of outdoor samples along roadsides, ND concentrations were lower than those measured in Turkish villages with MM mortality ranging from 20 to 50%. The physical and chemical properties of erionite from Turkey and ND are very similar and they showed identical biological activities. Considering the known 30- to 60-y latency for MM development, there is reason for concern for increased risk in ND in the future. Our findings indicate that implementation of novel preventive and early detection programs in ND and other erionite-rich areas of the United States, similar to efforts currently being undertaken in Turkey, is warranted.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21788493      PMCID: PMC3158231          DOI: 10.1073/pnas.1105887108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Epidemiology: Fear in the dust.

Authors:  Brendan Maher
Journal:  Nature       Date:  2010-12-16       Impact factor: 49.962

2.  TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis.

Authors:  Haining Yang; Maurizio Bocchetta; Barbara Kroczynska; Amira G Elmishad; Yuanbin Chen; Zemin Liu; Concetta Bubici; Brooke T Mossman; Harvey I Pass; Joseph R Testa; Guido Franzoso; Michele Carbone
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-23       Impact factor: 11.205

3.  Malignant mesotheliomas in a small village in the Anatolian region of Turkey: an epidemiologic study.

Authors:  M Artvinli; Y I Bariş
Journal:  J Natl Cancer Inst       Date:  1979-07       Impact factor: 13.506

4.  Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation.

Authors:  Haining Yang; Zeyana Rivera; Sandro Jube; Masaki Nasu; Pietro Bertino; Chandra Goparaju; Guido Franzoso; Michael T Lotze; Thomas Krausz; Harvey I Pass; Marco E Bianchi; Michele Carbone
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

5.  Early changes in the pleural mesothelium following intrapleural inoculation of the mineral fibre erionite and the subsequent development of mesotheliomas.

Authors:  R J Hill; R E Edwards; P Carthew
Journal:  J Exp Pathol (Oxford)       Date:  1990-02

6.  An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain/Urgüp in Anatolia.

Authors:  Y I Baris; A A Sahin; M Ozesmi; I Kerse; E Ozen; B Kolacan; M Altinörs; A Göktepeli
Journal:  Thorax       Date:  1978-04       Impact factor: 9.139

7.  Lung diseases due to environmental exposures to erionite and asbestos in Turkey.

Authors:  Salih Emri; Ahmet Demir; Meral Dogan; Hadi Akay; Bülent Bozkurt; Michele Carbone; Izzettin Baris
Journal:  Toxicol Lett       Date:  2002-02-28       Impact factor: 4.372

8.  Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

Authors:  Raja M Flores; Harvey I Pass; Venkatraman E Seshan; Joseph Dycoco; Maureen Zakowski; Michele Carbone; Manjit S Bains; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2008-02-14       Impact factor: 5.209

9.  Zeolite bodies in human lungs from Turkey.

Authors:  P Sebastien; A Gaudichet; J Bignon; Y I Baris
Journal:  Lab Invest       Date:  1981-05       Impact factor: 5.662

10.  Exposure to asbestos-containing vermiculite ore and respiratory symptoms among individuals who were children while the mine was active in Libby, Montana.

Authors:  Lisa C Vinikoor; Theodore C Larson; Thomas F Bateson; Linda Birnbaum
Journal:  Environ Health Perspect       Date:  2010-03-12       Impact factor: 9.031

View more
  58 in total

1.  Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma.

Authors:  Michele Carbone; Haining Yang
Journal:  Clin Cancer Res       Date:  2011-11-07       Impact factor: 12.531

Review 2.  Novel systemic therapy against malignant pleural mesothelioma.

Authors:  Michael R Mancuso; Joel W Neal
Journal:  Transl Lung Cancer Res       Date:  2017-06

Review 3.  In vitro experimental models of mesothelioma revisited.

Authors:  Anand Singh; Nathanael Pruett; Chuong D Hoang
Journal:  Transl Lung Cancer Res       Date:  2017-06

Review 4.  Mesothelioma: recent highlights.

Authors:  Michele Carbone; Haining Yang
Journal:  Ann Transl Med       Date:  2017-06

Review 5.  Environmental asbestos exposure and risk of mesothelioma.

Authors:  Curtis W Noonan
Journal:  Ann Transl Med       Date:  2017-06

Review 6.  The Cappadocia mesothelioma epidemic: its influence in Turkey and abroad.

Authors:  Salih A Emri
Journal:  Ann Transl Med       Date:  2017-06

7.  Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy.

Authors:  Raffit Hassan; Betsy Morrow; Anish Thomas; Tom Walsh; Ming K Lee; Suleyman Gulsuner; Meghana Gadiraju; Vasiliki Panou; Shaojian Gao; Idrees Mian; Javed Khan; Mark Raffeld; Snehal Patel; Liqiang Xi; Jun S Wei; Mary Hesdorffer; Jingli Zhang; Kathleen Calzone; Arpita Desai; Emerson Padiernos; Christine Alewine; David S Schrump; Seth M Steinberg; Hedy L Kindler; Mary-Claire King; Jane E Churpek
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-11       Impact factor: 11.205

8.  Reply to "No Increased Risk for Mesothelioma in Relation to Natural-Occurring Asbestos in Southern Nevada".

Authors:  Francine Baumann; Brenda J Buck; Rodney V Metcalf; Brett T McLaurin; Doug Merkler; Michele Carbone
Journal:  J Thorac Oncol       Date:  2015-07       Impact factor: 15.609

9.  CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma.

Authors:  Zeyana Rivera; Soldano Ferrone; Xinhui Wang; Sandro Jube; Haining Yang; Harvey I Pass; Shreya Kanodia; Giovanni Gaudino; Michele Carbone
Journal:  Clin Cancer Res       Date:  2012-08-14       Impact factor: 12.531

Review 10.  Geologic occurrences of erionite in the United States: an emerging national public health concern for respiratory disease.

Authors:  Bradley S Van Gosen; Thomas A Blitz; Geoffrey S Plumlee; Gregory P Meeker; M Patrick Pierson
Journal:  Environ Geochem Health       Date:  2013-01-12       Impact factor: 4.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.